LigaChem Biosciences Inc. (KOSDAQ:141080)
South Korea flag South Korea · Delayed Price · Currency is KRW
148,500
+100 (0.07%)
Aug 29, 2025, 11:40 AM KST

LigaChem Biosciences Revenue

LigaChem Biosciences had revenue of 51.58B KRW in the quarter ending March 31, 2025, with 66.07% growth. This brings the company's revenue in the last twelve months to 146.42B, up 154.45% year-over-year. In the year 2024, LigaChem Biosciences had annual revenue of 125.90B with 268.71% growth.

Revenue (ttm)
146.42B
Revenue Growth
+154.45%
P/S Ratio
36.74
Revenue / Employee
861.28M
Employees
170
Market Cap
5,379.81B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024125.90B91.75B268.71%
Dec 31, 202334.15B733.60M2.20%
Dec 31, 202233.41B1.26B3.90%
Dec 31, 202132.16B-25.34B-44.07%
Dec 31, 201957.50B32.26B127.81%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics5,031.69B
Celltrion3,748.95B
ALTEOGEN158.06B
Yuhan2,165.44B
SK Biopharmaceuticals620.28B
Peptron4.30B
PharmaResearch392.31B
HLB Co., Ltd.75.57B
Revenue Rankings